MPM Capital
Venture Capital
World-leading biotechnology investment firm with 30+ years of experience building and investing in biotech companies seeking to deliver transformative therapies to patients.
Boston, United States · 42+ investments · 22 portfolio companies
Early Stage
Growth
Seed
Biotech
Life Sciences
Oncology
biotechnology
cell therapy
drug discovery
gene therapy
immunology
neuroscience
- Headquarters
- Boston, United States
- Founded
- 1997
- Website
- mpmbioimpact.com
- AUM
- $3.0B
- Portfolio Companies
- 22
- Total Investments
- 42
- Last Investment
- Sep 2024
- Geographic Focus
- United States
Investment Thesis
We invest in private and public companies across the drug development process with the goal of transforming scientific breakthroughs into life saving medicines.
MPM Capital is a Venture Capital firm based in Boston, United States. It has made 42 investments in Biotech and Life Sciences, including Entrada Therapeutics, Trishula Therapeutics and Crossbow Therapeutics.
Portfolio22
S
SeaWolfInvestment History
Sign up to view investment history
Create a free account — 10 credits a month to unlock deal history, amounts, and round details.